Newsletter | July 22, 2026

07.22.26 -- Advancing Spatial Multiomics For Discovery: From Promise To Practice

Welcome to the Drug Discovery Online newsletter, delivering weekly updates on the latest developments in discovery and early-stage drug development. Based on your professional interests, we believe you’ll find it useful for improving research efficiency, staying current on emerging discovery technologies, and identifying the right partners to advance your programs. If not, you can unsubscribe at any time.

FEATURED EDITORIAL 

 GLP-1 Agonists In Addiction: Rationale And Drug Development 

By Tariq M. Ghafoor, MD, medical director, Aurora Behavioral Healthcare, Tempe, Arizona; founder, Transitions Center and AddictionRehab.com

GLP-1 receptor agonists represent a scientifically credible and potentially consequential avenue in addiction medicine.

 Advancing Spatial Multiomics For Discovery: From Promise To Practice 

By Ray Dogum, Chief Editor, Drug Discovery Online 

Spatial multiomics offers extraordinary biological insight, but high costs, tissue bottlenecks, and unclear clinical relevance still limit its reach.

 Why Rare Cancers Are Often Left Behind In Drug Discovery 

By Paul Romness, chair, chief executive officer, president, OS Therapies

Combining advances in AI with continued investment in rare cancer research could help bring new treatment options to patients who currently have very few.

INDUSTRY INSIGHTS 

 The Most Exciting Frontiers In Cell Therapy Development 

 Video | BD Biosciences 

From high-dimensional profiling to customizable Omic panels, new technologies are redefining cell therapy development—delivering better insights, efficiency, and scalability for researchers worldwide.

 Streamlined Selection Of In Vivo Predictive Dissolution Media 

 Webinar | Lonza 

Uncover the design of dissolution media to support biopredictive dissolution testing and a method for selecting practical, physiologically relevant media based on drug, formulation, and GI fluid properties.

 From Gene Editing To NGS-Based T Cell Characterization 

 Webinar | QIAGEN 

Gene-edited T cells targeting PD-1 and TIGIT are redefining approaches to cancer therapy. Explore how cell engineering and integrated genomic workflows uncover critical insights into T cell function.

 Five Practical Considerations To Move From Concept To Clinic 

 Webinar | Cytiva 

Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.

 Solid Form Screening Of Active Pharmaceutical Ingredients 

 Webinar | Lonza 

Discover the role of solid form services in helping meet accelerated timelines of the drug development lifecycle along with examples of robust workflows for fast and thorough solid form screens.

 A Human-Relevant Model Of The Liver Sinusoid 

 Application Note | Emulate 

This organ-on-a-chip model minimizes drug absorption while maintaining the essential architecture. Examine the specifications of this product engineered to model the human liver.

SOLUTIONS 

 Streamlining Magnetic Bead Purifications 

 INTEGRA Biosciences 

 Assay Development And Screening 

 Curia 

 On-Target And Off-Target Assessment Assays 

 MaxCyte, Inc.